Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Dicerna Pharmaceuticals Inc patents


Recent patent applications related to Dicerna Pharmaceuticals Inc. Dicerna Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Dicerna Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Dicerna Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dicerna Pharmaceuticals Inc-related inventors


Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna

This invention relates to compounds, compositions, and methods useful for reducing KRAS target RNA and protein levels via use of Dicer substrate siRNA (DsiRNA) agents possessing asymmetric end structures.... Dicerna Pharmaceuticals Inc

Ligand-modified double-stranded nucleic acids

The invention provides for double stranded nucleic acid molecules comprising a 5′ extension of the sense or antisense strand and further comprising a plurality of nucleotides that are conjugated to a ligand and methods of using the double-stranded nucleic acid molecules. Ligand-modified oligomers where the sense stands form a tetraloop... Dicerna Pharmaceuticals Inc

Therapeutic inhibition of lactate dehydrogenase and agents therefor

This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.... Dicerna Pharmaceuticals Inc

Methods and compositions for the specific inhibition of glycolate oxidase (hao1) by double-stranded rna

This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.... Dicerna Pharmaceuticals Inc

Methods and compositions for the specific inhibition of myc by double-stranded rna

This invention relates to compounds, compositions, and methods useful for reducing MYC target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.... Dicerna Pharmaceuticals Inc

Amine cationic lipids and uses thereof

The present invention relates to lipid compounds and uses thereof. In particular, the compounds include a class of cationic lipids having an amine moiety, such as an amino-amine or an amino-amide moiety. The lipid compounds are useful for in vivo or in vitro delivery of one or more agents (e.g.,... Dicerna Pharmaceuticals Inc

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-standed rna

This invention relates to compounds, compositions, and methods useful for reducing α-1 antitrypsin target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.... Dicerna Pharmaceuticals Inc

Acetyl-coa carboxylases

a medicament comprising the composition, and the like.... Dicerna Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dicerna Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dicerna Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###